Delivery Order SPE2DB25D3012-SPE2DB25FXANU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,604.02 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,774.76 for Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. The contract was competitively awarded without set-aside designation on September 5, 2025, with an ultimate completion date of September 8, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $2,010.60 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed price delivery order was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,773.84 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone therapeutic. The contract, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a firm fixed price delivery under a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,917.35 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone therapeutic product. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.84 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed price delivery order, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a routine pharmaceutical procurement under the company's broader relationship with DLA. The contract was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a $2,152.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone medication. This non-set-aside competitive award is scheduled for completion by September 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,164.10 to AmerisourceBergen Drug Corp for Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. This firm fixed-price, non-set-aside contract was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a relatively small transaction within the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,164.10 to AmerisourceBergen Drug Corp for Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. This firm fixed price contract, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, was competitively awarded with no set-aside designation. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,764.09 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 ml, a human growth hormone medication used to treat growth disorders and related conditions. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXANUDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,285.06 for Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. This firm fixed-price, non-set-aside contract was awarded on September 26, 2025, with an ultimate completion date of September 29, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement. The company's DLA IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. This delivery order for Norditropin reflects the company's ongoing role in supplying specialized pharmaceuticals across multiple therapeutic domains to the Defense Health Agency and other federal healthcare systems through competitive contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/26/25 |